Johnson & Johnson’s Ethicon subsidiary has announced that it will stop selling its power morcellators used for uterine fibroid removal surgery. Medical research has shown that use of the devices during minimally invasive laparoscopic hysterectomy and myomectomy procedures may carry a risk of spreading sarcoma cancer.
Johnson & Johnson Ethicon: No Recall
The company, which manufactured and sold uterine fibroid surgery morcellators since 1998, has stopped sales, promotion and distributing the medical devices after an April 17 FDA warning. The FDA warned doctors to avoid the devices because of the risk of spreading preexisting uterine sarcomas.